Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Mikhail

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Lancet (London, England)|September 6, 2003
Comments on the MRC/BHF Heart Protection StudyNasser Mikhail
Southern Medical Journal|September 30, 2003
Lessons learned from the Women's Health Initiative StudyNasser Mikhail
Mayo Clinic Proceedings|March 13, 2002
Octreotide treatment of acromegaly during pregnancyNasser Mikhail
Endocrine|February 11, 2014
Who would really benefit from DPP-4 inhibitors?Nasser Mikhail
Endocrine|February 5, 2014
Effects of incretin-based therapy in patients with heart failure and myocardial infarctionNasser Mikhail
Expert Opinion on Investigational Drugs|May 22, 2008
Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetesNasser Mikhail
Current Hypertension Reviews|May 9, 2018
Cardiovascular Effects of LiraglutideNasser Mikhail
Southern Medical Journal|February 18, 2015
Use of sodium-glucose cotransporter type 2 inhibitors in older adults with type 2 diabetes mellitusNasser Mikhail
The American Journal of Medicine|December 28, 2005
Primary care-based disease management for patients with diabetesNasser Mikhail, Dennis Cope
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2004
Visual vignette. Diabetic muscle infarctionNasser Mikhail, Dennis Cope
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Lancet (London, England)|September 6, 2003
Comments on the MRC/BHF Heart Protection StudyNasser Mikhail
Southern Medical Journal|September 30, 2003
Lessons learned from the Women's Health Initiative StudyNasser Mikhail
Mayo Clinic Proceedings|March 13, 2002
Octreotide treatment of acromegaly during pregnancyNasser Mikhail
Endocrine|February 11, 2014
Who would really benefit from DPP-4 inhibitors?Nasser Mikhail
Endocrine|February 5, 2014
Effects of incretin-based therapy in patients with heart failure and myocardial infarctionNasser Mikhail
Expert Opinion on Investigational Drugs|May 22, 2008
Incretin mimetics and dipeptidyl peptidase 4 inhibitors in clinical trials for the treatment of type 2 diabetesNasser Mikhail
Current Hypertension Reviews|May 9, 2018
Cardiovascular Effects of LiraglutideNasser Mikhail
Southern Medical Journal|February 18, 2015
Use of sodium-glucose cotransporter type 2 inhibitors in older adults with type 2 diabetes mellitusNasser Mikhail
The American Journal of Medicine|December 28, 2005
Primary care-based disease management for patients with diabetesNasser Mikhail, Dennis Cope
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 17, 2004
Visual vignette. Diabetic muscle infarctionNasser Mikhail, Dennis Cope
Pageof 6